Complement factor H (CFH)

The protein contains 1231 amino acids for an estimated molecular weight of 139096 Da.

 

Glycoprotein that plays an essential role in maintaining a well-balanced immune response by modulating complement activation. Acts as a soluble inhibitor of complement, where its binding to self markers such as glycan structures prevents complement activation and amplification on cell surfaces (PubMed:21285368, PubMed:25402769). Accelerates the decay of the complement alternative pathway (AP) C3 convertase C3bBb, thus preventing local formation of more C3b, the central player of the complement amplification loop (PubMed:19503104). As a cofactor of the serine protease factor I, CFH also regulates proteolytic degradation of already-deposited C3b (PubMed:18252712, PubMed:28671664). In addition, mediates several cellular responses through interaction with specific receptors. For example, interacts with CR3/ITGAM receptor and thereby mediates the adhesion of human neutrophils to different pathogens. In turn, these pathogens are phagocytosed and destroyed (PubMed:9558116, PubMed:20008295). (updated: Jan. 16, 2019)

Protein identification was indicated in the following studies:

  1. D'Alessandro and co-workers. (2017) Red blood cell proteomics update: is there more to discover? Blood Transfus. 15(2), 182-187.

Methods

The following articles were analysed to gather the proteome content of erythrocytes.

The gene or protein list provided in the studies were processed using the ID mapping API of Uniprot in September 2018. The number of proteins identified and mapped without ambiguity in these studies is indicated below.
Only Swiss-Prot entries (reviewed) were considered for protein evidence assignation.

PublicationIdentification 1Uniprot mapping 2Not mapped /
Obsolete
TrEMBLSwiss-Prot
Goodman (2013)2289 (gene list)227853205992269
Lange (2014)123412347281224
Hegedus (2015)2638262202352387
Wilson (2016)165815281702911068
d'Alessandro (2017)18261817201815
Bryk (2017)20902060101081942
Chu (2018)18531804553621387

1 as available in the article and/or in supplementary material
2 uniprot mapping returns all protein isoforms as one entry

The compilation of older studies can be retrieved from the Red Blood Cell Collection database.

The data and differentiation stages presented below come from the proteomic study and analysis performed by our partners of the GReX consortium, more details are available in their published work.

No sequence conservation computed yet.

Interpro domains
Total structural coverage: 0%
Model score: 0
No model available.

(right-click above to access to more options from the contextual menu)

VariantDescription
Confirmed at protein level
AHUS1
CFHD
AHUS1
AHUS1
Associated with ARMD4
CFHD
dbSNP:rs1061171
CFHD
dbSNP:rs35453854
Associated with basal laminar drusen
AHUS1
AHUS1
CFHD; with membranoproliferative glomerulonephritis
AHUS1
AHUS1
dbSNP:rs515299
AHUS1
AHUS1
Associated with hemolytic uremic syndrome and basal laminar drusen
AHUS1
AHUS1
AHUS1
CFHD
AHUS1
dbSNP:rs17575212
empty
dbSNP:rs534399
dbSNP:rs11539862
dbSNP:rs34362004
AHUS1
AHUS1
Associated with basal laminar drusen
dbSNP:rs35343172
CFHD
Associated with basal laminar drusen
CFHD
AHUS1
AHUS1
Confirmed at protein level
AHUS1
AHUS1
AHUS1
AHUS1
AHUS1
AHUS1
CFHD
AHUS1
AHUS1
AHUS1
AHUS1
AHUS1
AHUS1
CFHD and ARMD4
AHUS1
CFHD
AHUS1; atypical

No binding partner found

The reference OMIM entry for this protein is 126700

Basal laminar drusen
Drusen of bruch membrane
Drusen, cuticular
Drusen, early adult-onset, grouped

A number sign (#) is used with this entry because of evidence that a variant of the CFH gene (134370) influences the development of basal laminar drusen.

CLINICAL FEATURES

Drusen are extracellular deposits that accumulate below the retinal pigment epithelium on Bruch membrane. ('Drusen' is the plural for 'Druse,' German for 'nodule' or 'crystal.') 'Basal laminar drusen' refers to an early adult-onset drusen phenotype that shows a pattern of uniform small (25- to 75-micrometer), slightly raised yellow subretinal nodules randomly scattered in the macula (Boon et al., 2008). The term 'basal laminar drusen' is widely used but may be a misnomer because these deposits do not appear to correspond with nodular or diffuse thickening of the Bruch membrane. In later stages, these drusen often become more numerous, with clustered groups of drusen scattered throughout the retina. On fluorescein angiography, a typical 'stars in the sky' appearance may be observed. In time these small basal laminar drusen may expand and ultimately lead to a serous pigment epithelial detachment of the macula that may result in vision loss. Deutman and Jansen (1970) described a family in which 8 persons in 5 sibships had confirmed multiple drusen of Bruch membrane. There was no instance of male-to-male transmission but an affected male had 2 daughters who were negative by examination. They observed concordant monozygotic twins and affected boys 12 and 14 years old. They concluded that the family with 'crystalline retinal degeneration' reported by Evans (1950) had this condition. The authors also concluded that Doyne honeycomb choroiditis (126600) is the same condition. Round or oval lesions in almost grape-like clusters are concentrated in the posterior polar region. Pigmentary disturbances with secondary calcifications occur. The macula is almost always involved and may appear edematous or hemorrhagic. Loss of vision occurs during the progressive stages. This is considered a form of fleck retina disease (see 228980). One form of autosomal dominant drusen, malattia leventinese, or Doyne honeycomb degeneration of retina (126600), has been mapped to 2p. There may be other causes of hereditary drusen. Bok (2002) stated that there was widespread agreement among ophthalmologists that numerous large drusen, when present in both eyes, represent a significant risk factor for the evolution of early age-related macular dystrophy (ARMD1; 603075) into more advanced ARMD, with loss of central vision.

BIOCHEMICAL FEATURES

To understand the molecular basis of drusen formation, Crabb et al. (2002) developed a method for isolating microgram quantities of drusen and Bruch membrane for proteome analysis. They found oxidative protein modifications in drusen, supporting the hypothesis that oxidative injury contributes to the pathogenesis of ARMD and that these modifications may have a critical role in drusen formation.

MOLECULAR GENETICS

In 30 probands with a diagnosis of basal laminar drusen maculopathy, Boon et al. (2008) found the tyr402-to-his variant of the CFH gene, encoding complement factor H (134370.0008), in 48% of alleles. They found compound heterozygosity in affected members of 5 families for Y402H and another CFH mutation. Boon et al. (2008) concluded that their findings strongly supported a recessive disease model in a subgroup of patients with basal laminar drusen. In these families, individuals develop drusen when they carry a CFH mutation o ... More on the omim web site

Subscribe to this protein entry history

June 30, 2020: Protein entry updated
Automatic update: OMIM entry 126700 was added.

Jan. 21, 2019: Protein entry updated
Automatic update: Entry updated from uniprot information.

Oct. 19, 2018: Additional information
Initial protein addition to the database. This entry was referenced in Bryk and co-workers. (2017).